
AGM/EGM19 Nov 2026, 06:20 pm
Dipna Pharmachem Submits Annual Report for FY25-26
AI Summary
Dipna Pharmachem Limited has submitted its Annual Report for the Financial Year 2025-26, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report will be presented at the company's 15th Annual General Meeting (AGM) scheduled for September 30, 2026. The AGM agenda includes the adoption of audited financial statements, re-appointment of a director, and approval of material related party transactions with Dhara Pharmachem Private Limited. The report details company information, notices, board and auditor reports, financial statements, and committee compositions.
Key Highlights
- Annual Report for FY25-26 submitted.
- 15th AGM scheduled for September 30, 2026.
- Agenda includes financial statement adoption.
- Director re-appointment and related party transactions on agenda.
- Compliance with SEBI LODR Regulations confirmed.
Price Impact
More from DPL